LDLR and obesity disorder: Dyslipidemia promotes lipid uptake through the aberrant expression of LDL receptors (LDLR) and syndecan-1 on MM cells, while obesity-induced BMA remodeling inhibits apoptosis and exacerbates osteolytic lesions via the secretion of leptin and resistin (11).